Functional Variants at the 11q13 Risk Locus for Breast Cancer Regulate Cyclin D1 Expression through Long-Range Enhancers

被引：165

作者：

French, Juliet D. ^{[1
]}

Ghoussaini, Maya ^{[2
]}

Edwards, Stacey L. ^{[1
]}

Meyer, Kerstin B. ^{[3
]}

Michailidou, Kyriaki ^{[4
]}

Ahmed, Shahana ^{[2
]}

Khan, Sofia ^{[5
,6
]}

Maranian, Mel J. ^{[2
]}

O'Reilly, Martin ^{[3
]}

Hillman, Kristine M. ^{[1
]}

Betts, Joshua A. ^{[1
]}

Carro, Thomas ^{[3
]}

Bailey, Peter J. ^{[1
]}

Dicks, Ed ^{[2
]}

Beesley, Jonathan ^{[7
]}

Tyrer, Jonathan ^{[2
]}

Maia, Ana-Teresa ^{[3
]}

Beck, Andrew ^{[8
,9
]}

Knoblauch, Nicholas W. ^{[8
,9
]}

Chen, Constance ^{[10
]}

Kraft, Peter ^{[10
,11
]}

Barnes, Daniel ^{[4
]}

Gonzalez-Neira, Anna ^{[12
]}

Rosario Alonso, M. ^{[12
]}

Herrero, Daniel ^{[12
]}

Tessier, Daniel C. ^{[13
,14
]}

Vincent, Daniel ^{[13
,14
]}

Bacot, Francois ^{[13
,14
]}

Luccarini, Craig ^{[2
]}

Baynes, Caroline ^{[2
]}

Conroy, Don ^{[2
]}

Dennis, Joe ^{[4
]}

Bolla, Manjeet K. ^{[4
]}

Wang, Qin ^{[4
]}

Hopper, John L. ^{[15
]}

Southey, Melissa C. ^{[16
]}

Schmidt, Marjanka K. ^{[17
,18
]}

Broeks, Annegien ^{[18
]}

Verhoef, Senno ^{[19
]}

Cornelissen, Sten ^{[18
]}

Muir, Kenneth ^{[20
]}

Lophatananon, Artitaya ^{[20
]}

Stewart-Brown, Sarah ^{[20
]}

Siriwanarangsan, Pomthep ^{[21
]}

Fasching, Peter A. ^{[22
,23
]}

Loehberg, Christian R. ^{[23
]}

Ekici, Arif B. ^{[24
]}

Beckmann, Matthias W. ^{[23
]}

Peto, Julian ^{[25
]}

Silva, Isabel dos Santos ^{[25
]}

机构：

[1] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia

[2] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Oncol, Cambridge CB1 8RN, England

[3] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Cambridge CB2 ORE, England

[4] Univ Cambridge, Ctr Canc Genet Epidemiol, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England

[5] Univ Helsinki, Dept Obstet & Gynecol, Helsinki 00029, Finland

[6] Univ Helsinki, Cent Hosp, Helsinki 00029, Finland

[7] Queensland Inst Med Res, Dept Genet, Brisbane, Qld 4029, Australia

[8] Harvard Univ, Sch Med, Boston, MA 02215 USA

[9] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA

[10] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA

[11] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA

[12] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Human Genotyping CEGEN Unit, Madrid 28029, Spain

[13] Ctr Innovat Genome Quebec, Montreal, PQ H3A 0G1, Canada

[14] McGill Univ, Montreal, PQ H3A 0G1, Canada

[15] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3010, Australia

[16] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Melbourne, Vic 3010, Australia

[17] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, NL-1066 CX Amsterdam, Netherlands

[18] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Div Mol Pathol, NL-1066 CX Amsterdam, Netherlands

[19] Antoni van Leeuwenhoek Hosp, Netherlands Canc Inst, Family Canc Clin, NL-1066 CX Amsterdam, Netherlands

[20] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England

[21] Minist Publ Hlth, Bangkok 10400, Thailand

[22] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Dept Med, Los Angeles, CA 90095 USA

[23] Univ Hosp Erlangen, Dept Obstet & Gynecol, Univ Breast Ctr Franconia, D-91054 Erlangen, Germany

[24] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany

[25] Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Dept, London WC1E 7HT, England

[26] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England

[27] Guys & St Thomas NHS Fdn Trust Partnership Kings, NIHR Comprehens Biomed Res Ctr, Div Canc Studies, London SE1 9RT, England

[28] Univ Oxford, Welcome Trust Ctr Human Genet, Oxford 0X3 7BN, England

[29] Univ Oxford, Oxford Biomed Res Ctr, Oxford 0X3 7BN, England

[30] Galway Univ Hosp, Inst Clin Sci, Galway, Ireland

[31] Natl Univ Ireland, Galway, Ireland

[32] Heidelberg Univ, Dept Obstet & Gynecol, D-69115 Heidelberg, Germany

[33] Heidelberg Univ, Natl Ctr Tumor Dis, D-69120 Heidelberg, Germany

[34] German Canc Res Ctr, Mol Epidemiol Grp, D-69120 Heidelberg, Germany

[35] INSERM, Natl Inst Hlth & Med Res, CESP Ctr Res Epidemiol & Populat Hlth, Environm Epidemiol Canc Team,U1018, F-94807 Villejuif, France

[36] Univ Paris 11, UMRS 1018, F-94807 Villejuif, France

[37] Univ Paris Sorbonne Cite, UMR S775, INSERM, F-75270 Paris 06, France

[38] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Copenhagen Gen Populat Study, DK-2730 Herlev, Denmark

[39] Univ Copenhagen, Copenhagen Univ Hosp, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark

[40] Copenhagen Univ Hosp, Dept Breast Surg, Herlev Hosp, DK-2730 Herlev, Denmark

[41] Spanish Natl Canc Res Ctr CNIO, Human Canc Genet Program, Genet & Mol Epidemiol Grp, Madrid 28029, Spain

[42] Hosp Univ La Paz, Med Oncol Serv, Madrid 28046, Spain

[43] Hosp Monte Naranco, Serv Cirugia Gen & Especialidades, Oviedo 33012, Spain

[44] Ctr Invest Red Enfermedades Raras CIBERER, Madrid 28029, Spain

[45] Univ Calif Irvine, Dept Epidemiol, Irvine, CA 92697 USA

[46] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany

[47] Saarland Canc Registry, D-66024 Saarbrucken, Germany

[48] Tech Univ Munich, Div Gynaecol & Obstet, D-81675 Munich, Germany

[49] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany

[50] Univ Cologne, Dept Obstet & Gynaecol, Div Mol Gynecooncol, D-50931 Cologne, Germany

来源：

AMERICAN JOURNAL OF HUMAN GENETICS | 2013年 / 92卷 / 04期

关键词：

GENOME-WIDE ASSOCIATION; GROWTH-FACTOR RECEPTOR-2; ESTROGEN-RECEPTOR; DOWN-REGULATION; MULTIPLE LOCI; CELL-CYCLE; GATA-3; GENE; ALPHA; DIFFERENTIATION;

D O I：

10.1016/j.ajhg.2013.01.002

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Analysis of 4,405 variants in 89,050 European subjects from 41 case-control studies identified three independent association signals for estrogen-receptor-positive tumors at 11q13. The strongest signal maps to a transcriptional enhancer element in which the G allele of the best candidate causative variant rs554219 increases risk of breast cancer, reduces both binding of ELK4 transcription factor and luciferase activity in reporter assays, and may be associated with low cyclin D1 protein levels in tumors. Another candidate variant, rs78540526, lies in the same enhancer element. Risk association signal 2, rs75915166, creates a GATA3 binding site within a silencer element. Chromatin conformation studies demonstrate that these enhancer and silencer elements interact with each other and with their likely target gene, CCND1.

引用

页码：489 / 503

页数：15

共 50 条

[21] ERK5 and TORC regulate of Cyclin D1 expression in human breast cancer cells
Delepine, E.
Hipskind, R. A.
BULLETIN DU CANCER, 2008, 95 : S29 - S29
[22] THE INVOLVEMENT OF THE CHROMOSOME 11Q13 REGION IN HUMAN MALIGNANCIES - CYCLIN D1 AND EMS1 ARE 2 NEW CANDIDATE ONCOGENES - A REVIEW
SCHUURING, E
GENE, 1995, 159 (01) : 83 - 96
[23] Long-Range Modulation of PAG1 Expression by 8q21 Allergy Risk Variants
Vicente, Cristina T.
Edwards, Stacey L.
Hillman, Kristine M.
Kaufmann, Susanne
Mitchell, Hayley
Bain, Lisa
Glubb, Dylan M.
Lee, Jason S.
French, Juliet D.
Ferreira, Manuel A. R.
AMERICAN JOURNAL OF HUMAN GENETICS, 2015, 97 (02) : 329 - 336
[24] Expression of cyclin D1 and its relation with t(11;14)(q13;q32) and trisomy 11 in multiple myeloma patients
Akanksha, A. Kalal
Sucheta, Kumari
Rajesh, Krishna
Shubha, P. Bhat
Prashanth, Shetty
RESEARCH JOURNAL OF BIOTECHNOLOGY, 2022, 17 (11): : 29 - 36
[25] Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
Baxter, Joseph S.
Johnson, Nichola
Tomczyk, Katarzyna
Gillespie, Andrea
Maguire, Sarah
Brough, Rachel
Fachal, Laura
Michailidou, Kyriaki
Bolla, Manjeet K.
Wang, Qin
Dennis, Joe
Ahearn, Thomas U.
Andrulis, Irene L.
Anton-Culver, Hoda
Antonenkova, Natalia N.
Arndt, Volker
Aronson, Kristan J.
Augustinsson, Annelie
Becher, Heiko
Beckmann, Matthias W.
Behrens, Sabine
Benitez, Javier
Bermisheva, Marina
Bogdanova, Natalia, V
Bojesen, Stig E.
Brenner, Hermann
Brucker, Sara Y.
Cai, Qiuyin
Campa, Daniele
Canzian, Federico
Castelao, Jose E.
Chan, Tsun L.
Chang-Claude, Jenny
Chanock, Stephen J.
Chenevix-Trench, Georgia
Choi, Ji-Yeob
Clarke, Christine L.
Collaborators, Nbcs
Colonna, Sarah
Conroy, Don M.
Couch, Fergus J.
Cox, Angela
Cross, Simon S.
Czene, Kamila
Daly, Mary B.
Devilee, Peter
Doerk, Thilo
Dossus, Laure
Dwek, Miriam
Eccles, Diana M.
AMERICAN JOURNAL OF HUMAN GENETICS, 2021, 108 (07) : 1190 - 1203
[26] Functional characterization of a chr13q22.1 pancreatic cancer risk locus reveals long-range interaction and allele-specific effects on DIS3 expression
Hoskins, Jason W.
Ibrahim, Abdisamad
Emmanuel, Mickey A.
Manmiller, Sarah M.
Wu, Yinglun
O'Neill, Maura
Jia, Jinping
Collins, Irene
Zhang, Mingfeng
Thomas, Janelle V.
Rost, Lauren M.
Das, Sudipto
Parikh, Hemang
Haake, Jefferson M.
Matters, Gail L.
Kurtz, Robert C.
Bamlet, William R.
Klein, Alison
Stolzenberg-Solomon, Rachael
Wolpin, Brian M.
Yarden, Ronit
Wang, Zhaoming
Smith, Jill
Olson, Sara H.
Andresson, Thorkell
Petersen, Gloria M.
Amundadottir, Laufey T.
HUMAN MOLECULAR GENETICS, 2016, 25 (21) : 4726 - 4738
[27] Long Noncoding RNAs CUPID1 and CUPID2 Mediate Breast Cancer Risk at 11q13 by Modulating the Response to DNA Damage
Betts, Joshua A.
Marjaneh, Mahdi Moradi
Al-Ejeh, Fares
Lim, Yi Chieh
Shi, Wei
Sivakumaran, Haran
Tropee, Romain
Patch, Ann-Marie
Clark, Michael B.
Bartonicek, Nenad
Wiegmans, Adrian P.
Hillman, Kristine M.
Kaufmann, Susanne
Bain, Amanda L.
Gloss, Brian S.
Crawford, Joanna
Kazakoff, Stephen
Wani, Shivangi
Wen, Shu W.
Day, Bryan
Moller, Andreas
Cloonan, Nicole
Pearson, John
Brown, Melissa A.
Mercer, Timothy R.
Waddell, Nicola
Khanna, Kum Kum
Dray, Eloise
Dinger, Marcel E.
Edwards, Stacey L.
French, Juliet D.
AMERICAN JOURNAL OF HUMAN GENETICS, 2017, 101 (02) : 255 - 266
[28] The t(11;14) (q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330 kb centromeric from the cyclin D1 gene
Vaandrager, JW
Kluin, P
Schuuring, E
BLOOD, 1997, 89 (01) : 349 - 350
[29] Functional variant at the 12p13.31 CRC risk locus regulates LTBR expression through a long-range interaction
Gong, Yajie
Tian, Jianbo
Deng, Yao
Wan, Hao
Zhu, Ying
Chang, Jiang
Miao, Xiaoping
GENETIC EPIDEMIOLOGY, 2020, 44 (05) : 473 - 473
[30] Pan-cancer genomic landscape of the cyclin D1/FGF3,4,19 (11q13) amplicon including associations with HPV status, and ESR1 and AR alterations
Schrock, A. B.
Miller, V. A.
Alexander, B. M.
Ross, J. S.
Chung, J.
Ali, S. M.
ANNALS OF ONCOLOGY, 2019, 30 : 29 - 29

← 1 2 3 4 5 →